SterRx, LLC: Drug Recall
Recall #D-0307-2022 · 11/12/2021
Class II: Risk
Recall Details
- Recall Number
- D-0307-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- SterRx, LLC
- Status
- Terminated
- Date Initiated
- 11/12/2021
- Location
- Plattsburgh, NY, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3540 bags
Reason for Recall
Lack of Assurance of Sterility
Product Description
Succinylcholine Chloride Injection, 200 mg per 10 mL (20 mg per mL), 1,000 mL, Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-826-01.
Distribution Pattern
U.S.A. Nationwide
Other Recalls by SterRx, LLC
- Class II: Risk 07/07/2023
- Class II: Risk 07/07/2023
- Class II: Risk 07/07/2023
- Class II: Risk 07/07/2023
- Class II: Risk 07/07/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.